General Range

FORDOLAC ER

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

FORDOLAC ER Tablets by Fortune Labs contain Etodolac 600 mg, a prescription non-steroidal anti-inflammatory drug (NSAID) formulated for sustained relief of selected inflammatory pain conditions. Etodolac works by inhibiting cyclooxygenase enzymes involved in prostaglandin production, helping reduce pain, swelling and joint stiffness. FORDOLAC ER may be prescribed for symptomatic management of osteoarthritis, rheumatoid arthritis and other approved musculoskeletal conditions when clinically appropriate. Its extended-release formulation allows gradual release of the active ingredient over time. Available in convenient tablet blister strip packaging with a printed carton box, the medicine requires medical supervision, considering gastrointestinal health, kidney function, cardiovascular risks, potential drug interactions and recommended treatment duration. It does not cure arthritis or reverse joint damage.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Etodolac Extended-Release Tablets IP 600 mg
Packaging Type: Tablet Blister Strips with Printed Carton Box
Packaging Size: 10-tablet blister strip
Dosage Form: Tablet
Treatment: May help relieve pain, swelling and stiffness associated with osteoarthritis.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?